Investing Profile

Holger Reithinger

InvestorVC
Senior Advisor at Forbion
forbion.comMunich, Germany
Photo of Holger Reithinger, Advisor at Forbion

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Mikunda Cottrell & Company Network
126 CONNECTIONS
Mikunda Cottrell & Company Network
126 CONNECTIONS
Ludwig-Maximilians Universität München / University of Munich Network
39 CONNECTIONS
Ludwig-Maximilians-Universität München Network
32 CONNECTIONS
Forbion Network
17 CONNECTIONS
cb
Forbion Advisor
$100K - $5.0M
$1.5M
10
CompanyStageDateRound SizeTotal Raised
OMEICOS Therapeutics
Series CNov 2018$19M
$27M
Co-investors: Martin Pfister (High-Tech Gründerfonds)
Gotham Therapeutics
Series AOct 2018$54M
$54M
Allecra Therapeutics
Series BJun 2016$25M
Series AApr 2013$20M
$45M
Curetis
Series BNov 2014$18M
Series AOct 2011$13M
$31M
Co-investors: Rudy Dekeyser (EQT Group)
Santaris Pharma
Series UnknownJun 2012$12M
Series CDec 2007$30M
$42M
Co-investors: Martien van Osch (Forbion)
Agendia
Series ESep 2009$23M
Series DAug 2007$34M
$57M
Vice Chairman Epigenomics AGPresent
Aufsichtsrat 4SC AGPresent
Aufsichtsrat Curetis GmbHPresent
Board Member Allecra TherapeuticsPresent
Board Director Mikunda Cottrell & CompanyPresent
Member of the Board Mikunda Cottrell & CompanyPresent
Chairman Of The Board CatalYm GmbHPresent
Board Director Gotham TherapeuticsPresent
Board Member OMEICOS Therapeutics GmbHPresent
Board Observer Seamless TherapeuticsPresent
Senior Advisor ForbionPresent
Partner Global Life Science VenturesPresent
Heidelberg University Vordiplom Biology
Ludwig-Maximilians Universität München / University of Munich Diplom Biology
Ludwig-Maximilians-Universität München Diplom Biology
Sign in with Google →
Sign in with Google →